Stocks · Health care · Pharmaceutical Preparations

Curanex Pharmaceuticals Inc

CURX Clue Score33
United States Fiscal year ends December CIK 0002025942
$4.88 -8.10% Close, 12 Oct 2026
Price $4.88 +641.64% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 26 Aug 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2024Operating income−0.4Net income−0.4EPS, diluted−0.03Fiscal year 2025Operating income−4.2Net income−4.2EPS, diluted−0.17
FY2024FY2025
Operating income −0.4 −4.2
Net income −0.4 −4.2
Growth
EPS, diluted −0.03 −0.17

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2024Operating cash flow−0.6Fiscal year 2025Operating cash flow−10.5
FY2024FY2025
Operating cash flow −0.6 −10.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2024Shareholders’ equity0.5Fiscal year 2025Cash and securities5.0Shareholders’ equity11.2
FY2024FY2025
Cash and securities n/a 5.0
Shareholders’ equity 0.5 11.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a 3.0
0.3 1.3
−0.4 −4.2
Growth
−0.4 −4.2
Growth
Per share
−0.03 −0.17
−0.03 −0.17
Growth
13.3 25.5
13.3 25.5
Growth

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 2 years on file.